{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "The present invention is directed to the novel forms of risperidone, designated Form A, Fomi B and Fonn E. Methods for their preparation are also disclosed. The present invention also relates to processes for making risperidone. Pharmaceutical compositions containing the new forms of zisperidone and methods of using them are also disclosed.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E401313-T1: [Translated] PRODUCTION OF RISPERIDONE on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401313-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/myft-cq2u", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/myft-cq2u", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E401313-T1: [Translated] PRODUCTION OF RISPERIDONE"}